Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
This scientific programme is part of the ESC’s Global Scientific Activities - a series of international educational courses in collaboration with cardiology partners all over the world.
In close collaboration with the Great Wall International Cardiology Congress, the ESC brings highlights in key topics from ESC Congress to China as part of the Final Programme of the 27th Great Wall International Congress of Cardiology (GW-ICC) & Asia Pacific Heart Congress 2016 & International Congress Cardiovascular Prevention and Rehabilitation 2016 and the World Heart Failure congress 2016 and the 21st Congress Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy.
Room 310, 3rd floor
Chairpersons : M. Roffi (Switzerland), LEI Han (China), TBD (China), ZHU Tiangang (China)
10:30 Heart Failure - S. Achenbach (Germany)
11:00 Commentary - XU Dingli (China)
11:10 Imaging - F. Pinto (Portugal)
11:40 Commentary - FU Guosheng (China)
Chairpersons: Prof Changsheng Ma (China), Prof Yunlong Xia (China)
12:30 ESC Congress 2016 in Rome - Take home messages – F. Pinto (Portugal)
13:00 RE-LY, focusing on Asian
Chairpersons: S. Achenbach (Germany), DONG Jianzeng (China), QIN Shu (China) & JIANG Chenyang (China)
14:00 Heart Failure - S. Achenbach (Germany)
14:30 Commentary - ZHANG Jian (China)
14:45 Atrial Fibrillation - F. Pinto (Portugal)
15:15 Commentary - DONG Jianzeng (China)
Chairpersons : S. Gielen (Germany), LI Yigang (China), TBD (China), HOU Jingbo (China)
08:30 Prevention - S. Gielen (Germany)
09:00 Acute Coronary Syndromes - M. Roffi (Switzerland)
09:30 Interventional Cardiology - M. Roffi (Switzerland)
Chairpersons : M. Roffi (Switzerland), SHI Zhongwei (China) & LI Jianjun (China)10:30 Prevention - S. Gielen (Germany) 11:00 Commentary - LIU Jing (China) 11:10 Dyslipidemia - S. Gielen (Germany) 11:40 Commentary - LI Jianjun (China) 11:50 Conclusion - M. Roffi (Switzerland)
Chairpersons: Prof. Ma Changsheng (China), Prof. Zhu Jun (China)12:30 Introduction - Ma Changsheng (China), Zhu Jun (China) 12:35 ESC AF guideline update - Yang Jiefu (China)12:50 Topic 2 : Rivaroxaban’s clinical evidence: from phase III to real life – Manesh Patel (United State of America)13:05 Topic 3: Practice consideration in NOAC selection - Li Yiheng (China)13:20 Q&A and closing remarks - Ma Changsheng (China), Zhu Jun (China)
If you missed the "ESC in China at GWICC 2015" sessions or would like to review the content please access the slides:
Read the press release about stroke being the leading cause of death in China.
You can also download slides, videos, congress reports and abstracts from ESC Congress 2015, including the joint GWICC/ESC session thanks to ESC Congress 365. All you need to do is create your free My ESC Account.
China National Convention Center (CNCC)
Building No 1 Court 8 Beichen West Road
The ESC Global Scientific Activities are supported by Bayer, Boehringer Ingelheim and SERVIER in the form of an unrestricted educational grant.
© 2016 European Society of Cardiology. All rights reserved